Sign in Subscribe
Diseases

Prevalence of Pseudomonas aeruginosa Colonization in Chronic Obstructive Pulmonary Disease

Strategic Insights

— 1 min read

Chronic obstructive pulmonary disease (COPD) affects millions worldwide, with a significant portion of patients colonized with Pseudomonas aeruginosa. Research has shown a strong association between prior exposure to antibiotics and inhaled corticosteroids and increased risk of PA colonization. A recent study conducted by researchers from Tianjin Medical University General Hospital found that approximately 5.6% of patients with stable COPD are colonized with PA. Moreover, previous exposure to antibiotics and ICSs increased the risk of PA colonization, while azithromycin therapy reduced exacerbations in PA colonized COPD patients. The eradication rate of PA with inhaled antibiotics was approximately 52%.

Key Takeaways:

  • The prevalence of Pseudomonas aeruginosa colonization in patients with stable COPD is approximately 5.6%.
  • Prior exposure to antibiotics and inhaled corticosteroids increases the risk of PA colonization in COPD patients.
  • Azithromycin therapy reduced exacerbations in PA colonized COPD patients.
  • The eradication rate of PA with inhaled antibiotics was approximately 52%.
  • The study included 39 studies with a total of 32,753 cases.
  • The pooled prevalence of PA colonization was 5.6% (95% CI 0.04-0.07).
  • The odds ratio (OR) for antibiotic exposure was 2.85 (95% CI 1.62-5.01) and for ICS exposure was 1.89 (95% CI 1.12-3.19).

Statistics:

  • 5.6% of patients with stable COPD are colonized with Pseudomonas aeruginosa (95% CI 0.04-0.07).
  • The odds ratio (OR) for antibiotic exposure was 2.85 (95% CI 1.62-5.01).
  • The odds ratio (OR) for ICS exposure was 1.89 (95% CI 1.12-3.19).
  • Azithromycin therapy reduced exacerbations by 43% (95% CI -0.77 to -0.10).
  • The eradication rate of PA with inhaled antibiotics was 52% (95% CI 46-57).

Sources:

  • NewsRx. Studies from Tianjin Medical University General Hospital Provide New Data on Chronic Obstructive Pulmonary Disease (Prevalence, Risk Factors, and Antibiotic Intervention of Lower Airway Pseudomonas aeruginosa Colonization in Patients with ...). Drug Week. October 17, 2025; p 3071.
  • Prevalence, Risk Factors, and Antibiotic Intervention of Lower Airway Pseudomonas aeruginosa Colonization in Patients with Stable Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-Analysis. COPD, 2025;22(1):2564743.

Read more